Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count
- PMID: 11350669
- DOI: 10.1089/08892220151126661
Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count
Abstract
To explore the role of antibody-dependent cellular cytotoxicity (ADCC) in controlling HIV-1 infection, ADCC was compared with plasma RNA and CD4+ cell count in 40 patients not receiving antiretroviral therapy and in seven patients after the initiation of treatment. Among untreated patients, ADCC effector cell function of peripheral blood mononuclear cells, measured by (51)Cr release assay, correlated inversely with viral load (R = -0.42, p = 0.007) and directly with CD4+ cell count (R = 0.52, p = 0.001). On the other hand, HIV-1-specific ADCC antibody level correlated directly with viral load, but only among patients with high CD4+ cell counts. Therapy-induced changes in ADCC effector cell function correlated strongly with changes in CD4+ cell count (R = 0.86, p = 0.014), whereas there was no consistent pattern of change in ADCC antibody with therapy. In a novel assay, ADCC reduced virus yield from CD4+ lymphocytes infected with a primary HIV isolate. ADCC may contribute to control of viremia, and CD4+ lymphocytes likely play a role in ADCC effector and antibody functions.
Similar articles
-
gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease.AIDS. 1997 Dec;11(15):1807-14. doi: 10.1097/00002030-199715000-00004. AIDS. 1997. PMID: 9412698
-
Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):345-353. doi: 10.1097/QAI.0000000000001380. J Acquir Immune Defic Syndr. 2017. PMID: 28346319 Clinical Trial.
-
Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.J Virol. 2015 Dec 30;90(6):2993-3002. doi: 10.1128/JVI.02973-15. J Virol. 2015. PMID: 26719277 Free PMC article.
-
The CD4(+) T cell response to HIV-1.Curr Opin Immunol. 2000 Aug;12(4):381-6. doi: 10.1016/s0952-7915(00)00104-7. Curr Opin Immunol. 2000. PMID: 10899031 Review.
-
The utility of ADCC responses in HIV infection.Curr HIV Res. 2008 Nov;6(6):515-9. doi: 10.2174/157016208786501472. Curr HIV Res. 2008. PMID: 18991616 Review.
Cited by
-
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity.J Clin Invest. 2013 May;123(5):2183-92. doi: 10.1172/JCI65708. Epub 2013 Apr 8. J Clin Invest. 2013. PMID: 23563315 Free PMC article.
-
Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors.Retrovirology. 2009 Jun 21;6:60. doi: 10.1186/1742-4690-6-60. Retrovirology. 2009. PMID: 19545395 Free PMC article.
-
Challenges in mucosal HIV vaccine development: lessons from non-human primate models.Viruses. 2014 Aug 15;6(8):3129-58. doi: 10.3390/v6083129. Viruses. 2014. PMID: 25196380 Free PMC article. Review.
-
Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections.Vaccines (Basel). 2019 Aug 30;7(3):103. doi: 10.3390/vaccines7030103. Vaccines (Basel). 2019. PMID: 31480293 Free PMC article. Review.
-
B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.PLoS One. 2011;6(8):e22653. doi: 10.1371/journal.pone.0022653. Epub 2011 Aug 23. PLoS One. 2011. PMID: 21886768 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials